Literature DB >> 9257157

Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers.

N M Davies1, F Jamali.   

Abstract

Recently, NSAID-induced changes in both the structure and function of the distal intestine have been found to occur more frequently and with greater toxicological significance than previously thought. We have previously validated a suitable animal model to evaluate intestinal permeability changes using orally administered 51Cr-EDTA that correlates with intestinal ulceration. In this study we investigated the suitability of metronidazole and the nitroxide stable free radical scavenger (tempo) as protective agents against NSAID-induced intestinal permeability. Male Sprague-Dawley rats were dosed with two doses of metronidazole (50 mg/kg, 12 and 1 h pre-NSAID) or a single 100 mg/kg dose of tempo 1 h prior to NSAIDs. The urinary excretion of the orally administered marker 51Cr-EDTA was measured. Both tempo and metronidazole dramatically reduced indomethacin (20 mg/kg) and flurbiprofen (10 mg/kg)-induced intestinal permeability. All the animals exposed to indomethacin alone died within 48-96 h and presented with histological evidence of drug-induced enteropathy, ulceration and frank peritonitis. Protection by tempo and metronidazole suggests that free radicals and/or bacteria may be important mediators in the pathogenesis of intestinal mucosal damage induced by NSAIDs. Nitric oxide donor compounds used concomitantly with NSAIDs may protect gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257157     DOI: 10.1177/096032719701600701

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

1.  Does metronidazole cure cap polyposis by its antiinflammatory actions instead of by its antibiotic action? A case study.

Authors:  Kayoko Shimizu; Hideki Koga; Mitsuo Iida; Takashi Yao; Katsuya Hirakawa; Kazunori Hoshika; Yoshiki Mikami; Ken Haruma
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

2.  Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism.

Authors:  A Z Leite; A M Sipahi; A O Damião; A M Coelho; A T Garcez; M C Machado; C A Buchpiguel; F P Lopasso; M L Lordello; C L Agostinho; A A Laudanna
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

3.  Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.

Authors:  Hiroki Endo; Takuma Higurashi; Kunihiro Hosono; Eiji Sakai; Yusuke Sekino; Hiroshi Iida; Yasunari Sakamoto; Tomoko Koide; Hirokazu Takahashi; Masato Yoneda; Chikako Tokoro; Masahiko Inamori; Yasunobu Abe; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2011-05-10       Impact factor: 7.527

Review 4.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

Review 5.  Determining small bowel integrity following drug treatment.

Authors:  Simon Smale; Ingvar Bjarnason
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

6.  Antioxidant effects of metronidazole in colonic tissue.

Authors:  M A Pélissier; P Marteau; P Pochart
Journal:  Dig Dis Sci       Date:  2006-12-07       Impact factor: 3.487

7.  Measurement of gut permeability using fluorescent tracer agent technology.

Authors:  Richard B Dorshow; Carla Hall-Moore; Nurmohammad Shaikh; Michael R Talcott; William A Faubion; Thomas E Rogers; Jeng Jong Shieh; Martin P Debreczeny; James R Johnson; Roy B Dyer; Ravinder J Singh; Phillip I Tarr
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.